Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients.
about
Antipsychotic drug treatment for elderly people with late-onset schizophreniaRecommendations for the management of behavioral and psychological symptoms of dementia.Clinical utility of the risperidone formulations in the management of schizophrenia.Behavioral and psychological signs and symptoms of dementia: a practicing psychiatrist's viewpoint.Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials?[Critical study of the treatment of 159 elderly in psychiatric consultation].Psychosis and behavioural symptoms of dementia: defining the role of neuroleptic interventions.Tardive dyskinesias in the elderly.Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trialApproach to managing behavioural disturbances in dementia.Antipsychotic treatment for late-life schizophrenia.New wine in old bottle: late-life psychosisCo-occurring depressive symptoms in the older patient with schizophrenia.Risperidone associated tardive dyskinesia--a less common phenomenon.Treatment of the special patient with schizophrenia.Caring for the whole person: integrated health care for older adults with severe mental illness and medical comorbidity.Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects.Outpatient Follow-Up Visit after Hospital Discharge Lowers Risk of Rehospitalization in Patients with Schizophrenia: A Nationwide Population-Based StudyTardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?Evaluation of pharmacotherapy in geriatric patients after performing complete geriatric assessment at a diagnostic day clinic.Pharmacological treatment of the psychosis of Alzheimer's disease: what is the best approach?Rethinking antipsychotic formulary policy.ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.Beyond the Black Box: What is The Role for Antipsychotics in Dementia?Alternatives to atypical antipsychotics for the management of dementia-related agitation.Atypical antipsychotics in the elderly: a review of therapeutic trends and clinical outcomes.Management of schizophrenia in late life with antipsychotic medications: a qualitative review.Comparing the risk of tardive dyskinesia in older adults with first-generation and second-generation antipsychotics: a systematic review and meta-analysis.α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group.Evaluation of tiapride in agitated elderly outpatients: an open study.Risperidone and tardive dyskinesia.Determinants of antipsychotic medication use among older people living in aged care homes in Australia.Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro.Atypical (second generation) antipsychotic treatment response in very late-onset schizophrenia-like psychosis.Incidence of tardive dyskinesia in older adult patients treated with olanzapine or conventional antipsychotics.Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.
P2860
Q24203649-91E3A087-C748-4038-8F76-498CC988BC38Q30327961-4220BF1F-6EC2-4E91-A097-1C98751FBB43Q30429721-11961428-236A-4B25-8C54-97274B0DE29DQ30473431-622280C0-9E6C-426B-8A41-9253FF4B51BEQ33203719-C5EB17EA-A8E2-4649-8992-1D7AC5831F52Q33480648-EC806ED5-3D71-4C96-9E77-80B7D418A80EQ33591977-095340F6-4110-4550-96B1-BB5A738CC2E9Q33991925-61C8F345-B96E-4925-8665-59E869C58246Q34465775-729BC86E-246E-474E-80DF-41AEAD105C6AQ34465779-FABCAC9F-C9DA-45ED-B9D5-C70C85EE079DQ34480263-786CD81C-A085-49F7-9333-67E19E42CCC6Q34683770-B59A690D-021B-4172-95F7-C95871959BF3Q34749227-574C3152-54AA-419B-AB86-325EF420A06AQ34976609-91A54BFA-B9A5-4966-9FB5-DA476FDDC2D1Q35008098-AEBD9C4D-3D09-447A-9882-365F7688DEA9Q35222287-3837683E-DD22-4953-B2F2-FB8DE5AF3615Q35236370-5D58FC88-D972-44FC-AB91-63234F357052Q35947395-A5ED9DE8-EC4E-4749-947F-D56AD0791137Q35987703-DA45CE17-F658-45B7-9F1D-A42CA4CD7230Q36205371-E0318852-9865-44AE-ABFD-4DD6428734BBQ36346334-CC9B783C-0B2D-4044-810B-8440A4E829D5Q36592621-D3E274D3-F444-464C-BA66-0AE64969678FQ36680977-54DE9226-207A-47B5-A0A6-14C753AED414Q36729609-4D405052-E230-4626-928C-487098E2CFA7Q36883316-3744DDE3-6E81-4816-83B3-DF6C13359932Q36885358-ED61543D-FA65-4F42-A103-A15240B50364Q37094302-F7869B79-9A87-4517-B925-EE945355E1A4Q37151230-E32EB186-A92C-444B-A78F-2F11A85569ADQ37575663-D5C2AD6F-06E1-47F9-B593-7AD6A9EEB182Q37960898-DCA48837-AD69-4250-882D-5D202DD82B48Q38672583-A5A6C891-5E24-4599-844F-C99ECFC080CFQ39279185-4B1BCBDB-BDFE-4B7B-A183-DC9EA50CD212Q42628400-2C52D7AE-BA9F-446C-8736-15C5852FC869Q42686820-88457105-510E-4847-916E-08EBF50833B5Q43619666-C493D3E0-D886-46DA-94F1-9D7BDC5DF322Q43814362-48F973F5-8E81-4E98-9E69-216D8AD64834Q44684238-FB00663C-D078-416B-8C8F-6BD0CFC333C7Q46032957-476107D0-30A3-4EFF-96DB-B93DF4174A63Q46079349-E04C62BF-B40F-4B08-B89F-EFC17D9D2B7AQ46111815-F8BF2224-5733-4E0E-AE43-04963485BDF5
P2860
Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Lower incidence of tardive dys ...... haloperidol in older patients.
@en
type
label
Lower incidence of tardive dys ...... haloperidol in older patients.
@en
prefLabel
Lower incidence of tardive dys ...... haloperidol in older patients.
@en
P2093
P1476
Lower incidence of tardive dys ...... haloperidol in older patients.
@en
P2093
P304
P356
10.1111/J.1532-5415.1999.TB01595.X
P407
P577
1999-06-01T00:00:00Z